Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers

Acute Leukemia Extended 4 Test

Acute Leukemia Extended 4 is a comprehensive diagnostic test that is critical in the diagnosis, monitoring, and treatment planning of patients with suspected acute leukemia. Acute leukemia is a type of cancer that affects the blood and bone marrow and is characterized by an abnormal increase in immature white blood cells. This panel combines three crucial tests - Flow Cytometry Acute Leukemia (FCM AL) Characterization Panel, Karyotyping, and Fluorescence In Situ Hybridization (FISH) with four markers. These tests provide detailed insights into the genetic makeup of leukemia cells and help to categorize leukemia more accurately.

  • Test Name: Acute Leukemia Extended 4: FCM AL Characterization Panel, Karyotyping, and FISH Four Markers
  • Sample Type: Bone marrow aspiration/ blood
  • Preparations Required: No fasting required. Follow the instructions provided by the doctor or the lab.
  • Report Time: 12 Days

The FCM AL Characterization Panel employs flow cytometry to identify and categorize the types of cells present in the sample. Karyotyping involves a microscopic examination of the patient’s chromosomes and is essential for identifying chromosomal abnormalities. FISH is used to detect and locate specific DNA sequences on chromosomes. It utilizes fluorescent probes that bind to only those parts of the chromosome that has a high degree of sequence complementarity.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

This test is crucial in diagnosing acute leukemia. It helps in identifying the type of leukemia and any genetic mutations that may affect treatment and prognosis. The information obtained is invaluable in creating a personalized treatment plan.

No, fasting is not required for this test.

This test is usually advised when a doctor suspects a diagnosis of acute leukemia based on clinical symptoms and initial blood tests. It may also be recommended for monitoring during treatment.

The test provides detailed information about the type of acute leukemia and helps in identifying genetic abnormalities and mutations. This information is critical for staging the disease and planning treatment.

The frequency of this test depends on the clinical status of the patient and the doctor's recommendations. It is generally performed at the time of diagnosis and may be repeated at various stages of treatment to monitor response.

Normal values would indicate no presence of abnormal or immature cells and no chromosomal abnormalities. However, in patients with acute leukemia, the presence of such cells and abnormalities is expected.

There are no specific precautions. However, it is advisable to inform the doctor of any medications or supplements you are taking, as some medications may interfere with the test results.

Factors affecting the levels include the type of leukemia, stage of the disease, the patient's age, health, and response to any ongoing treatment.

If the test results are abnormal, it is important to consult a hematologist or an oncologist, who specialize in blood disorders and cancer, respectively.

A bone marrow aspirate (BMA) or peripheral blood (PB) sample is usually collected for this test. The procedure for collecting a bone marrow sample involves inserting a needle into the bone to collect a small amount of bone marrow.

You may experience some discomfort or pain during the collection of the bone marrow sample. Local anesthesia is used to minimize pain.

Fluorescence In Situ Hybridization (FISH) is a test that uses fluorescent probes to detect specific DNA sequences on chromosomes. It is essential for identifying chromosomal changes that are too small to be detected under a microscope with conventional cytogenetic techniques.

Karyotyping is a test that evaluates the number, size, and shape of a person's chromosomes. It helps to detect structural abnormalities in chromosomes, such as deletions, translocations, and duplications.

Acute Leukemia Extended 4 is an essential test for the diagnosis and management of acute leukemia. It provides critical information on the genetic makeup of leukemia cells which guides the treatment planning. It’s important to follow your doctor’s instructions regarding the preparation for the test and to provide complete medical history as certain medications may interfere with the results. Consulting a hematologist or an oncologist is vital for the proper understanding and management of the condition.

Acute Leukemia Extended 4 (FCM AL Characterization Panel and Karyotyping and FISH Four Markers)
₹ 24500
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet